The Valley Desk

NCT06567743 · Interventional trial

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Overall registry status Recruiting

Phase 2

Conditions High-Risk Non-Muscle-Invasive Bladder Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov